Likewise, the overexpression of this gene resulting from the administration of AgNPs could increase patient survival with CRC because other researchers have also reported that the downexpression of ATP5A1 is associated with a low survival rate in colon cancer patients [31]. The gene discussed is ATP5F1A; the disease is colorectal carcinoma.